An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

Blood

Volumn 86, Issue 10, 1995, Pages 3961-3969

  Weaver, Charles H ^a   Hazelton, Bonni ^a   Birch, Robert ^a   Palmer, Peter ^a   Allen, Cathy ^a   Schwartzberg, Lee ^a   West, William ^a  

^a Response Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GROWTH FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; DRUG MEGADOSE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; OVARY CANCER; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

EID: 0028856612     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.10.3961.bloodjournal86103961     Document Type: Article

References (40)

1. Appelbaum FR, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB: Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52:85, 1978
2. To LB, Robers MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQK, Dart GW, Harvoth N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA: Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277, 1992
3. Hill RS, Mazza P, Amos D: Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplant 4:69, 1989
4. Nemunaitis J, Rabinowe WN, Singer JW: Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773, 1991
5. Sheridan WP, Morstyn G, Wolf M: Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891, 1989
6. Taylor KM, Jagannath S, Spitzer G: Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's Disease. J Clin Oncol 7:1791, 1989
7. To LB, Dyson PG, Branford AL: Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haempopoietic reconstitution in acute non-lymphoblastic leukemia. Bone Marrow Transplant 2:103, 1987
8. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemothrapy. Lancet 1:640, 1992
9. Schwartzberg L, Birch R, Blanco R, Wittlin F, Muscato J, Tauer K, Hazelton B, West W: Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 11:369, 1993
10. Henon PR, Liang H, Beck-Wirth G, Eisenmann JC, Lepers M, Wunder E, Kandel G: Collection of circulating stem cells and their use for autograft in adults with acute lymphoblastic leukemia. Nouv Rev Fr Hematol 30:229, 1988
11. Koerbling M, Doerken B, Ho AD, Pezutto A, Hunstein W, Fliedner TM: Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Concise Rep Blood 67:529, 1986
12. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2:580, 1989
13. Bell AJ, Figes A, Oscier DG, Hamblin TJ: Peripheral blood stem cell autografts in the treatment of lymphoid malignancies: Initial experience in three patients. Br J Haematol 66:63, 1987
14. Bensinger WI, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clark E, Clift R, Hansen J, Shieds T, Storb R, Weaver CH, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993
15. Gianni AM, Bregni M, Siena S: Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high-dose chemotherapy? Hematol Oncol 7:139, 1989
16. Schwartzberg L, Birch R, Hazelton B, Tauer K, Lee P, Altemose R, George C, Blanco R, Wittlin F, Cohen J, Muscato J, West W: Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother 1:317, 1992
17. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Paleaz J, Reich E, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Frei E III, Antman K: Mobilization of peripheral blood progenitor cells by chemotherapy and granylocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992
18. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBPCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994
19. Emminger W, Emminger-Schmidmeier W, Hocker P, Hinterberger W, Gardner H: Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Bone Marrow Transplant 4:415, 1989
20. Kawano Y, Takaue Y, Watanabe T, Saito SI, Abe T, Hirao A, Sato J, Nonomiya T, Suzue T, Koyama T, Shimokawa T, Yokobayaschi A, Asano S, Masaoka T, Takaku F, Kuroda Y: Effects of progenitor cell dose and preleukapheresis use of human recombinantgranulocyte colony-stimulating factor on the recovery of hematopoiesis after stem cell autografting in children. Exp Hematol 21:103, 1993
21. Haas R, Hohaus S, Ehrhardt R, Goldschmidt H, Hunstein W: Autografting with rhG-CSF mobilized blood stem cells in patients with chemosensitive malignancies. Blood 80:238a, 1992 (abstr, suppl 1)
22. Bender JG, Williams SF, Myers S, Nottleman D, Lee WJ, Unverzagt KL, Walker D, To LB, Epps DEV: Characterization of chemotherapy mobilized peripheral blood progenitor cells fo use in autologous stem cell transplantation. Bone Marrow Transplant 10:281, 1992
23. Menichella G, Pierelli L, Foddai ML, Paoloni A, Vittori M, Serafini R, Benedetti P, Scambia G, Baiochi G, Greggi S, Laurelli G, Salerno G, Mancuso S, Manco G, Bizzi B: Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer. Br J Haematol 79:444, 1991
24. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R: Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 21:508, 1993
25. Mortimer J, Hendricks D, Goodnough LT, Zutter M, Fears C, Brown RA: Pheresis of peripheral blood progenitor cells directed by CD34 counts. J Clin Oncol 12:467, 1993
26. Spencer V, Smith J, Kulkarni S, Petuska P, Broun G, Dunphy F, Martini T, Daniel F, Spitzer G: Does transplantation of high number of CD34 cells predict more rapid engraftment following high-dose chemotherapy. J Clin Oncol 11:131, 1992
27. Hazelton B, Birch R, Schwartzberg L, West WH, Dolan C: CD34 yield alone is sufficient to determine adequacy of peripheral blood progenitor cell (PBPC) products. Proc Am Assoc Cancer Res 35:205, 1994
28. Philip T, Chauvin F, Armitage JO: PARMA International Protocol: Pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 77:1587, 1991
29. Weaver CH, Bensinger WI, Appelbaum K, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Trueblood K, Klarnet J, Buckner CD: Phase I study of high-dose busulfan, melphalan, thiotepa with autologous stem cell support in patients with refractory malignancies. Bone Marrow Transplant 14:813, 1994
30. Weaver CH, Birch R, Schwartzberg LS, West W: High-dose chemotherapy and autologous stem cell transplantation for breast cancer, in Buckner CD, Clift R (eds): Technical and Biological Components of Marrow Transplantation. Norwell, MA, Kluwer Academic, 1995, p 59
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
32. Cox DR: Regression models and life-tables. J R Stat Soc Series B 34:187, 1972
33. Clark JG, Hansen JA, Hertz MI: Idiopathic pneumonia syndrome following bone marrow transplantation. Am Rev Respir Dis 147:1601, 1993
34. Spitzer G, Spencer V, Dunphy F, Kulkarni S, Petruska P, Velasuez W, Ruppel L, Adkins D: Are growth factors (GF) needed after peripheral blood stem cell (PBPC) transplantation? A randomized study to evaluate the question. J Clin Oncol 12:467, 1993
35. Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE: Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 83:3808, 1994
36. Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H: CD34 positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 19:1079, 1991
37. Castaigne S, Calvo F, Douay L: Successful haematopoietic reconstitution using autologous peripheral blood monocleated cells in a patient with acute promyelocytic leukemia. Br J Haematol 63:209, 1986
38. Brice P, Marolleau JP, Dombret H, Leapage E, Baruchel A, Adam M, Micleas JM, Sitthy X, Gisselbrecht C: Autologous peripheral blood stem cell transplantation after high-dose therapy in patients with advanced lymphomas. Bone Marrow Transplant 9:337, 1992
39. Reiffers J, Faberes C, Boiron JM, Marit G, Foures C, Ferrer AM, Cony-Makhoul P, Puntous M, Bernard P, Vezon G, Broustet A: Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: Analysis of factors affecting the rate of engraftment. J Hematother 3:185, 1994
40. Schwartzberg L, Birch R, Weaver C, West W: The effect of varying durations of granulocyte-colony stimulating factor (G-CSF) on neutrophil engraftment and supportive care following peripheral blood progenitor cell (PBPC) infusion. Blood 84:91a, 1994 (abstr, suppl 1)